-
Apple Bites Into Trademark Battle ... Over The Humble Fruit Itself
Wednesday, June 21, 2023 - 6:20am | 467Apple Inc. (NASDAQ:AAPL) has raised eyebrows by attempting to secure intellectual property rights over depictions of the apple fruit itself. This peculiar move highlights the increasing obsession of corporations with intellectual property rights (IPRs) as they strive to gain a...
-
UBS Downgrades AbbVie; Here's What Changed Analysts' View
Monday, September 25, 2017 - 9:29am | 537UBS downgraded shares of AbbVie Inc (NYSE: ABBV), citing valuation and a likely delay in the U.S. biosimilar competition for Humira. Humira is AbbVie's best-selling drug approved to treat multiple indications such as rheumatoid arthritis, psoriatic arthritis and Crohn's disease, among others....
-
JPMorgan Says Qualcomm China Settlement Has 'Positive Read-Across' For Ericsson And Nokia
Tuesday, February 10, 2015 - 1:03pm | 258Sandeep Deshpande of JPMorgan on Monday commented in a note that QUALCOMM, Inc.'s (NASDAQ: QCOM) settlement with Chinese regulators and its new licensing terms in China are a positive for European wireless IPR holders. "We would argue that in only 4G, Ericsson [(NYSE: ERIC)] and Nokia [(NYSE: NOK...
-
JP Morgan Comments On Ericsson And Apple's IPR Lawsuits
Wednesday, January 14, 2015 - 1:16pm | 230Ericsson (ADR) (NASDAQ: ERIC) and Apple Inc. (NASDAQ: AAPL) recently filed IPR-based lawsuits against each other. Sandeep Deshpande of JP Morgan on Wednesday commented in a note that the move is an attempt by Ericsson to monetize its IPR portfolio better. Apple is fighting back in court,...